| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| David P. Hochman | Director, Chairman of the Board | $1.26M | Feb 10, 2022 | ||
| Darren Sherman | Director | $1.15M | Feb 10, 2022 | ||
| Mark Pomeranz | President and COO, Director | $133K | Feb 10, 2022 | ||
| Andrew Taylor | Chief Financial Officer | $118K | Feb 10, 2022 | ||
| Shervin J. Korangy | Director | $97.1K | Feb 10, 2022 | ||
| Elad Amor | Chief Accounting Officer | Jun 2, 2023 | |||
| Sonja Nelson | Director | Mar 5, 2024 | |||
| Ravit Ram | Chief Financial Officer | Jun 2, 2023 | |||
| Timothy P. Moran | Director | Mar 5, 2024 | |||
| Orchestra BioMed Holdings, Inc. | 10%+ Owner | Sep 12, 2023 | |||
| Scott Durbin | Director | Mar 5, 2024 | |||
| Gary J. Pruden | Director | Mar 5, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|